This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

 
Web www.patentalert.com

< N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands

> Vagal down-regulation obesity treatment
~ 00423